AM Press ReleasesMedical AMOrthopedic Implants

Osseus obtains FDA 510(k) clearance of Pisces-SA spinal implant

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

Osseus, an innovative spinal solutions company, obtained FDA 510(k) clearance and launch of the Pisces-SA Standalone ALIF Interbody System. The Pisces-SA interbody can be used with both bone screws and alternative fixation bone anchors allowing for increased intraoperative flexibility.

Osseus obtains FDA 510(k) clearance of Pisces-SA 3D printed spinal implant to stabilize injured spinal segments Biomechanical testing proved that the Pisces-SA anchors provide better expulsion resistance and perform comparably with traditional screw-based standalone ALIF constructs in stabilizing injured spinal segments. The Pisces-SA is the first of its kind to provide this level of expulsion resistance and segmental stabilization using an alternative fixation method.

The Pisces-SA anchors allow for a streamlined, direct anterior approach which facilitates minimal access and improved operational efficiency. Dr. Michael Hisey, an orthopedic surgeon with Texas Back Institute in Plano, TX, describes the system’s versatility, “I’ve used screws […], and I’ve used the blade-type constructs, but I’ve never used a device where you could make that choice intraoperatively. I really like that ability to make my decision at the time.”

This innovative platform integrates a highly porous 3D printed interbody with anatomical morphology designed for full osseointegration with streamlined instrumentation to facilitate a minimally invasive approach. Osseus believes the Pisces-SA sets the new standard for Standalone ALIF devices.

“Receiving FDA approval for the Pisces™-SA is the culmination of relentless work from our R&D department and surgeon design team. We feel this product launch will solidify Osseus as one of the leading innovators in the spine industry,” says Rob Pace, Founder and CEO of Osseus. “Since our inception, we have pushed the envelope creating minimally invasive products to help simplify and streamline procedures. This product hits that mark, and we are excited to introduce it to the market. This is a special day for our company and for the team of surgeons who have provided extensive input on this groundbreaking product.”

Consumer Products AM 2024

1,346 polymer and metal AM companies and 143 end-users. Consumer products AM generated $2.6 billion in 2023. Segment expected to grow to $28 billion by 2033 at 26.8% CAGR. This new market study fro...

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services


Join our 12,000+ Professional community and get weekly AM industry insights straight to your inbox. Our editor-curated newsletter equips executives, engineers, and end-users with crucial updates, helping you stay ahead.